{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:59:30Z","timestamp":1791932370229,"version":"4.3.4"},"publisher-location":"Singapore","reference-count":67,"publisher":"Springer Nature Singapore","isbn-type":[{"value":"9789819901128","type":"print"},{"value":"9789819901135","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-981-99-0113-5_18","type":"book-chapter","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:23:23Z","timestamp":1678879403000},"page":"329-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Replicating-Competent VSV-Vectored Pseudotyped Viruses"],"prefix":"10.1007","author":[{"given":"Fei","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"18_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0092-8674(81)90143-4","volume":"23","author":"LE Iverson","year":"1981","unstructured":"Iverson, L.E., Rose, J.K.: Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell. 23, 477\u2013484 (1981). https:\/\/doi.org\/10.1016\/0092-8674(81)90143-4","journal-title":"Cell"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"8388","DOI":"10.1073\/pnas.92.18.8388","volume":"92","author":"SP Whelan","year":"1995","unstructured":"Whelan, S.P., Ball, L.A., Barr, J.N., Wertz, G.T.: Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc.Natl.Acad.Sci.USA. 92, 8388\u20138392 (1995)","journal-title":"Proc.Natl.Acad.Sci.USA"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","volume":"92","author":"ND Lawson","year":"1995","unstructured":"Lawson, N.D., Stillman, E.A., Whitt, M.A., Rose, J.K.: Recombinant vesicular stomatitis viruses from DNA. Proc.Natl.Acad.Sci.USA. 92, 4477\u20134481 (1995). https:\/\/doi.org\/10.1073\/pnas.92.10.4477","journal-title":"Proc.Natl.Acad.Sci.USA"},{"key":"18_CR4","doi-asserted-by":"publisher","first-page":"11359","DOI":"10.1073\/pnas.93.21.11359","volume":"93","author":"MJ Schnell","year":"1996","unstructured":"Schnell, M.J., Buonocore, L., Kretzschmar, E., Johnson, E., Rose, J.K.: Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc.Natl.Acad.Sci.USA. 93, 11359\u201311365 (1996). https:\/\/doi.org\/10.1073\/pnas.93.21.11359","journal-title":"Proc.Natl.Acad.Sci.USA"},{"key":"18_CR5","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1128\/JVI.70.4.2318-2323.1996","volume":"70","author":"MJ Schnell","year":"1996","unstructured":"Schnell, M.J., Buonocore, L., Whitt, M.A., Rose, J.K.: The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J.Virol. 70, 2318\u20132323 (1996). https:\/\/doi.org\/10.1128\/JVI.70.4.2318-2323.1996","journal-title":"J.Virol."},{"key":"18_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1006\/viro.1999.0120","volume":"268","author":"K Haglund","year":"2000","unstructured":"Haglund, K., Forman, J., Krausslich, H.G., Rose, J.K.: Expression of human immunodeficiency virus type 1 gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Virologie. 268, 112\u2013121 (2000). https:\/\/doi.org\/10.1006\/viro.1999.0120","journal-title":"Virologie"},{"key":"18_CR7","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.1128\/JVI.71.8.5982-5989.1997","volume":"71","author":"E Kretzschmar","year":"1997","unstructured":"Kretzschmar, E., Buonocore, L., Schnell, M.J., Rose, J.K.: High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J.Virol. 71, 5982\u20135989 (1997). https:\/\/doi.org\/10.1128\/JVI.71.8.5982-5989.1997","journal-title":"J.Virol."},{"key":"18_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1006\/viro.1998.9535","volume":"254","author":"JS Kahn","year":"1999","unstructured":"Kahn, J.S., Schnell, M.J., Buonocore, L., Rose, J.K.: Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virologie. 254, 81\u201391 (1999). https:\/\/doi.org\/10.1006\/viro.1998.9535","journal-title":"Virologie"},{"key":"18_CR9","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1128\/JVI.71.7.5060-5068.1997","volume":"71","author":"JE Johnson","year":"1997","unstructured":"Johnson, J.E., Schnell, M.J., Buonocore, L., Rose, J.K.: Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J.Virol. 71, 5060\u20135068 (1997). https:\/\/doi.org\/10.1128\/JVI.71.7.5060-5068.1997","journal-title":"J.Virol."},{"key":"18_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1006\/viro.1998.9429","volume":"251","author":"JE Johnson","year":"1998","unstructured":"Johnson, J.E., Rodgers, W., Rose, J.K.: A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions. Virologie. 251, 244\u2013252 (1998). https:\/\/doi.org\/10.1006\/viro.1998.9429","journal-title":"Virologie"},{"key":"18_CR11","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","volume":"73","author":"A Roberts","year":"1999","unstructured":"Roberts, A., Buonocore, L., Price, R., Forman, J., Rose, J.K.: Attenuated vesicular stomatitis viruses as vaccine vectors. J.Virol. 73, 3723\u20133732 (1999). https:\/\/doi.org\/10.1128\/JVI.73.5.3723-3732.1999","journal-title":"J.Virol."},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s0092-8674(00)80350-5","volume":"90","author":"MJ Schnell","year":"1997","unstructured":"Schnell, M.J., Johnson, J.E., Buonocore, L., Rose, J.K.: Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell. 90, 849\u2013857 (1997). https:\/\/doi.org\/10.1016\/s0092-8674(00)80350-5","journal-title":"Cell"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"6937","DOI":"10.1128\/JVI.73.8.6937-6945.1999","volume":"73","author":"E Boritz","year":"1999","unstructured":"Boritz, E., Gerlach, J., Johnson, J.E., Rose, J.K.: Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J.Virol. 73, 6937\u20136945 (1999). https:\/\/doi.org\/10.1128\/JVI.73.8.6937-6945.1999","journal-title":"J.Virol."},{"key":"18_CR14","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1128\/jvi.78.10.5458-5465.2004","volume":"78","author":"M Garbutt","year":"2004","unstructured":"Garbutt, M., et al.: Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J.Virol. 78, 5458\u20135465 (2004). https:\/\/doi.org\/10.1128\/jvi.78.10.5458-5465.2004","journal-title":"J.Virol."},{"key":"18_CR15","first-page":"513","volume":"3","author":"RN Harty","year":"2001","unstructured":"Harty, R.N., Brown, M.E., Hayes, F.P., Wright, N.T., Schnell, M.J.: Vaccinia virus-free recovery of vesicular stomatitis virus. J. Mol. Microbiol. Biotechnol. 3, 513\u2013517 (2001)","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"18_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100209","volume":"1","author":"TA Farzani","year":"2020","unstructured":"Farzani, T.A., Chov, A., Herschhorn, A.: A protocol for displaying viral envelope glycoproteins on the surface of vesicular stomatitis viruses. STAR Protoc. 1, 100209 (2020). https:\/\/doi.org\/10.1016\/j.xpro.2020.100209","journal-title":"STAR Protoc"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li, W., et al.: Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 426, 450\u2013454 (2003). https:\/\/doi.org\/10.1038\/nature02145","journal-title":"Nature"},{"key":"18_CR18","doi-asserted-by":"publisher","first-page":"786-786 e781","DOI":"10.1016\/j.cell.2020.06.033","volume":"182","author":"J Mercer","year":"2020","unstructured":"Mercer, J., Lee, J.E., Saphire, E.O., Freeman, S.A.: SnapShot: enveloped virus entry. Cell. 182, 786-786 e781 (2020). https:\/\/doi.org\/10.1016\/j.cell.2020.06.033","journal-title":"Cell"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-virology-100114-055119","volume":"2","author":"S Pillay","year":"2015","unstructured":"Pillay, S., Carette, J.E.: Hunting viral receptors using haploid cells. Annual review of virology. 2, 219\u2013239 (2015). https:\/\/doi.org\/10.1146\/annurev-virology-100114-055119","journal-title":"Annual review of virology"},{"key":"18_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature10348","volume":"477","author":"JE Carette","year":"2011","unstructured":"Carette, J.E., et al.: Ebola virus entry requires the cholesterol transporter Niemann-pick C1. Nature. 477, 340\u2013343 (2011). https:\/\/doi.org\/10.1038\/nature10348","journal-title":"Nature"},{"key":"18_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1128\/JVI.01832-09","volume":"84","author":"AC Wong","year":"2010","unstructured":"Wong, A.C., Sandesara, R.G., Mulherkar, N., Whelan, S.P., Chandran, K.: A forward genetic strategy reveals destabilizing mutations in the ebolavirus glycoprotein that alter its protease dependence during cell entry. J.Virol. 84, 163\u2013175 (2010). https:\/\/doi.org\/10.1128\/JVI.01832-09","journal-title":"J.Virol."},{"key":"18_CR22","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1126\/science.1252480","volume":"344","author":"LT Jae","year":"2014","unstructured":"Jae, L.T., et al.: Virus entry. Lassa virus entry requires a trigger-induced receptor switch. Science. 344, 1506\u20131510 (2014). https:\/\/doi.org\/10.1126\/science.1252480","journal-title":"Science"},{"key":"18_CR23","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1126\/science.1178955","volume":"326","author":"JE Carette","year":"2009","unstructured":"Carette, J.E., et al.: Haploid genetic screens in human cells identify host factors used by pathogens. Science. 326, 1231\u20131235 (2009). https:\/\/doi.org\/10.1126\/science.1178955","journal-title":"Science"},{"key":"18_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003911","volume":"10","author":"J Petersen","year":"2014","unstructured":"Petersen, J., et al.: The major cellular sterol regulatory pathway is required for Andes virus infection. PLoS Pathog. 10, e1003911 (2014). https:\/\/doi.org\/10.1371\/journal.ppat.1003911","journal-title":"PLoS Pathog."},{"key":"18_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00801-15","volume":"6","author":"LM Kleinfelter","year":"2015","unstructured":"Kleinfelter, L.M., et al.: Haploid genetic screen reveals a profound and direct dependence on cholesterol for hantavirus membrane fusion. mBio. 6, e00801 (2015). https:\/\/doi.org\/10.1128\/mBio.00801-15","journal-title":"mBio."},{"key":"18_CR26","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.chom.2017.10.002","volume":"22","author":"M Raaben","year":"2017","unstructured":"Raaben, M., et al.: NRP2 and CD63 are host factors for lujo virus cell entry. Cell Host Microbe. 22, 688\u2013696. e685 (2017). https:\/\/doi.org\/10.1016\/j.chom.2017.10.002","journal-title":"Cell Host Microbe."},{"key":"18_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41586-018-0702-1","volume":"563","author":"RK Jangra","year":"2018","unstructured":"Jangra, R.K., et al.: Protocadherin-1 is essential for cell entry by New World hantaviruses. Nature. 563, 559\u2013563 (2018). https:\/\/doi.org\/10.1038\/s41586-018-0702-1","journal-title":"Nature."},{"key":"18_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009996","volume":"17","author":"A Volland","year":"2021","unstructured":"Volland, A., et al.: Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants. PLoS Pathog. 17, e1009996 (2021). https:\/\/doi.org\/10.1371\/journal.ppat.1009996","journal-title":"PLoS Pathog."},{"key":"18_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cell.2020.10.028","volume":"184","author":"J Wei","year":"2021","unstructured":"Wei, J., et al.: Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection. Cell. 184, 76\u201391 (2021). https:\/\/doi.org\/10.1016\/j.cell.2020.10.028","journal-title":"Cell."},{"key":"18_CR30","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.abd0827","volume":"369","author":"J Hansen","year":"2020","unstructured":"Hansen, J., et al.: Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science. 369, 1010\u20131014 (2020). https:\/\/doi.org\/10.1126\/science.abd0827","journal-title":"Science"},{"key":"18_CR31","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.abd0831","volume":"369","author":"A Baum","year":"2020","unstructured":"Baum, A., et al.: Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science. 369, 1014\u20131018 (2020). https:\/\/doi.org\/10.1126\/science.abd0831","journal-title":"Science"},{"key":"18_CR32","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/302490a0","volume":"302","author":"GL Smith","year":"1983","unstructured":"Smith, G.L., Mackett, M., Moss, B.: Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature. 302, 490\u2013495 (1983). https:\/\/doi.org\/10.1038\/302490a0","journal-title":"Nature"},{"key":"18_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/311067a0","volume":"311","author":"B Moss","year":"1984","unstructured":"Moss, B., Smith, G.L., Gerin, J.L., Purcell, R.H.: Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature. 311, 67\u201369 (1984). https:\/\/doi.org\/10.1038\/311067a0","journal-title":"Nature"},{"key":"18_CR34","doi-asserted-by":"publisher","unstructured":"Vrba, S.M., Kirk, N.M., Brisse, M.E., Liang, Y., Ly, H.: Development and applications of viral vectored vaccines to combat zoonotic and emerging public health threats. Vaccines (Basel). 8 (2020). https:\/\/doi.org\/10.3390\/vaccines8040680","DOI":"10.3390\/vaccines8040680"},{"key":"18_CR35","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1128\/JVI.72.6.4704-4711.1998","volume":"72","author":"A Roberts","year":"1998","unstructured":"Roberts, A., et al.: Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J.Virol. 72, 4704\u20134711 (1998). https:\/\/doi.org\/10.1128\/JVI.72.6.4704-4711.1998","journal-title":"J.Virol."},{"key":"18_CR36","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1099\/vir.0.19050-0","volume":"84","author":"B Schlereth","year":"2003","unstructured":"Schlereth, B., et al.: Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose. J.Gen.Virol. 84, 2145\u20132151 (2003). https:\/\/doi.org\/10.1099\/vir.0.19050-0","journal-title":"J.Gen.Virol."},{"key":"18_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0168-1702(00)00164-7","volume":"69","author":"PR Grigera","year":"2000","unstructured":"Grigera, P.R., et al.: Presence of bovine viral diarrhea virus (BVDV) E2 glycoprotein in VSV recombinant particles and induction of neutralizing BVDV antibodies in mice. Virus Res. 69, 3\u201315 (2000). https:\/\/doi.org\/10.1016\/s0168-1702(00)00164-7","journal-title":"Virus Res."},{"key":"18_CR38","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/s0092-8674(01)00482-2","volume":"106","author":"NF Rose","year":"2001","unstructured":"Rose, N.F., et al.: An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell. 106, 539\u2013549 (2001). https:\/\/doi.org\/10.1016\/s0092-8674(01)00482-2","journal-title":"Cell"},{"key":"18_CR39","doi-asserted-by":"publisher","first-page":"10903","DOI":"10.1128\/jvi.74.23.10903-10910.2000","volume":"74","author":"NF Rose","year":"2000","unstructured":"Rose, N.F., Roberts, A., Buonocore, L., Rose, J.K.: Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1. J.Virol. 74, 10903\u201310910 (2000). https:\/\/doi.org\/10.1128\/jvi.74.23.10903-10910.2000","journal-title":"J.Virol."},{"key":"18_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1128\/JVI.01515-07","volume":"82","author":"D Cooper","year":"2008","unstructured":"Cooper, D., et al.: Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice. J.Virol. 82, 207\u2013219 (2008). https:\/\/doi.org\/10.1128\/JVI.01515-07","journal-title":"J.Virol."},{"key":"18_CR41","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1128\/JVI.01911-06","volume":"81","author":"DK Clarke","year":"2007","unstructured":"Clarke, D.K., et al.: Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations. J.Virol. 81, 2056\u20132064 (2007). https:\/\/doi.org\/10.1128\/JVI.01911-06","journal-title":"J.Virol."},{"key":"18_CR42","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1128\/JVI.10.6.1231-1235.1972","volume":"10","author":"JM Kelley","year":"1972","unstructured":"Kelley, J.M., Emerson, S.U., Wagner, R.R.: The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. J.Virol. 10, 1231\u20131235 (1972). https:\/\/doi.org\/10.1128\/JVI.10.6.1231-1235.1972","journal-title":"J.Virol."},{"key":"18_CR43","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nm1258","volume":"11","author":"SM Jones","year":"2005","unstructured":"Jones, S.M., et al.: Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat.Med. 11, 786\u2013790 (2005). https:\/\/doi.org\/10.1038\/nm1258","journal-title":"Nat.Med."},{"key":"18_CR44","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.1016\/j.vaccine.2008.09.082","volume":"26","author":"TW Geisbert","year":"2008","unstructured":"Geisbert, T.W., et al.: Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine. 26, 6894\u20136900 (2008). https:\/\/doi.org\/10.1016\/j.vaccine.2008.09.082","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"18_CR45","doi-asserted-by":"publisher","first-page":"S404","DOI":"10.1086\/520591","volume":"196","author":"SM Jones","year":"2007","unstructured":"Jones, S.M., et al.: Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever. J. Infect. Dis. 196(Suppl 2), S404\u2013S412 (2007). https:\/\/doi.org\/10.1086\/520591","journal-title":"J. Infect. Dis."},{"key":"18_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005547","volume":"4","author":"X Qiu","year":"2009","unstructured":"Qiu, X., et al.: Mucosal immunization of cynomolgus macaques with the VSVDeltaG\/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses. PLoS One. 4, e5547 (2009). https:\/\/doi.org\/10.1371\/journal.pone.0005547","journal-title":"PLoS One"},{"key":"18_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030002","volume":"3","author":"H Feldmann","year":"2007","unstructured":"Feldmann, H., et al.: Effective post-exposure treatment of Ebola infection. PLoS Pathog. 3, e2 (2007). https:\/\/doi.org\/10.1371\/journal.ppat.0030002","journal-title":"PLoS Pathog."},{"issue":"Suppl 3","key":"18_CR48","doi-asserted-by":"publisher","first-page":"S1090","DOI":"10.1093\/infdis\/jir379","volume":"204","author":"Y Tsuda","year":"2011","unstructured":"Tsuda, Y., et al.: Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infection. J. Infect. Dis. 204(Suppl 3), S1090\u2013S1097 (2011). https:\/\/doi.org\/10.1093\/infdis\/jir379","journal-title":"J. Infect. Dis."},{"key":"18_CR49","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1016\/j.vaccine.2014.08.028","volume":"32","author":"G Wong","year":"2014","unstructured":"Wong, G., et al.: Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents. Vaccine. 32, 5722\u20135729 (2014). https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.028","journal-title":"Vaccine"},{"key":"18_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000225","volume":"4","author":"TW Geisbert","year":"2008","unstructured":"Geisbert, T.W., et al.: Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates. PLoS Pathog. 4, e1000225 (2008). https:\/\/doi.org\/10.1371\/journal.ppat.1000225","journal-title":"PLoS Pathog."},{"key":"18_CR51","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1414216","volume":"376","author":"JA Regules","year":"2017","unstructured":"Regules, J.A., et al.: A recombinant vesicular stomatitis virus Ebola vaccine. N.Engl.J.Med. 376, 330\u2013341 (2017). https:\/\/doi.org\/10.1056\/NEJMoa1414216","journal-title":"N.Engl.J.Med."},{"key":"18_CR52","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","volume":"374","author":"ST Agnandji","year":"2016","unstructured":"Agnandji, S.T., et al.: Phase 1 trials of rVSV Ebola vaccine in Africa and Europe. N.Engl. J.Med. 374, 1647\u20131660 (2016). https:\/\/doi.org\/10.1056\/NEJMoa1502924","journal-title":"N.Engl. J.Med."},{"key":"18_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002402","volume":"14","author":"ST Agnandji","year":"2017","unstructured":"Agnandji, S.T., et al.: Safety and immunogenicity of rVSVDeltaG-ZEBOV-GP Ebola vaccine in adults and children in Lambarene, Gabon: a phase I randomised trial. PLoS Med. 14, e1002402 (2017). https:\/\/doi.org\/10.1371\/journal.pmed.1002402","journal-title":"PLoS Med."},{"key":"18_CR54","doi-asserted-by":"publisher","first-page":"E819","DOI":"10.1503\/cmaj.170074","volume":"189","author":"MS ElSherif","year":"2017","unstructured":"ElSherif, M.S., et al.: Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial. CMAJ. 189, E819\u2013E827 (2017). https:\/\/doi.org\/10.1503\/cmaj.170074","journal-title":"CMAJ"},{"key":"18_CR55","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S1473-3099(17)30313-4","volume":"17","author":"DG Heppner Jr","year":"2017","unstructured":"Heppner Jr., D.G., et al.: Safety and immunogenicity of the rVSVG-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study. Lancet Infect. Dis. 17, 854\u2013866 (2017). https:\/\/doi.org\/10.1016\/S1473-3099(17)30313-4","journal-title":"Lancet Infect. Dis."},{"key":"18_CR56","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","volume":"15","author":"A Huttner","year":"2015","unstructured":"Huttner, A., et al.: The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial. Lancet Infect. Dis. 15, 1156\u20131166 (2015). https:\/\/doi.org\/10.1016\/S1473-3099(15)00154-1","journal-title":"Lancet Infect. Dis."},{"key":"18_CR57","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","volume":"389","author":"AM Henao-Restrepo","year":"2017","unstructured":"Henao-Restrepo, A.M., et al.: Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola ca Suffit!). Lancet. 389, 505\u2013518 (2017). https:\/\/doi.org\/10.1016\/S0140-6736(16)32621-6","journal-title":"Lancet"},{"key":"18_CR58","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","volume":"386","author":"AM Henao-Restrepo","year":"2015","unstructured":"Henao-Restrepo, A.M., et al.: Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 386, 857\u2013866 (2015). https:\/\/doi.org\/10.1016\/S0140-6736(15)61117-5","journal-title":"Lancet"},{"key":"18_CR59","doi-asserted-by":"publisher","first-page":"98","DOI":"10.15585\/mmwr.su6503a14","volume":"65","author":"MA Widdowson","year":"2016","unstructured":"Widdowson, M.A., et al.: Implementing an Ebola vaccine study - Sierra Leone. MMWR Suppl. 65, 98\u2013106 (2016). https:\/\/doi.org\/10.15585\/mmwr.su6503a14","journal-title":"MMWR Suppl"},{"key":"18_CR60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cell.2020.03.011","volume":"181","author":"E Ollmann Saphire","year":"2020","unstructured":"Ollmann Saphire, E.: A Vaccine against Ebola Virus. Cell. 181, 6 (2020). https:\/\/doi.org\/10.1016\/j.cell.2020.03.011","journal-title":"Cell"},{"key":"18_CR61","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.chom.2020.07.018","volume":"28","author":"JB Case","year":"2020","unstructured":"Case, J.B., et al.: Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis in mice. Cell Host Microbe. 28, 465\u2013474 e464 (2020). https:\/\/doi.org\/10.1016\/j.chom.2020.07.018","journal-title":"Cell Host Microbe"},{"key":"18_CR62","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.chom.2020.06.020","volume":"28","author":"ME Dieterle","year":"2020","unstructured":"Dieterle, M.E., et al.: A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition. Cell Host Microbe. 28, 486\u2013496 e486 (2020). https:\/\/doi.org\/10.1016\/j.chom.2020.06.020","journal-title":"Cell Host Microbe"},{"key":"18_CR63","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1038\/s41467-020-20228-7","volume":"11","author":"Y Yahalom-Ronen","year":"2020","unstructured":"Yahalom-Ronen, Y., et al.: A single dose of recombinant VSV-\u0394G-spike vaccine provides protection against SARS-CoV-2 challenge. Nat. Commun. 11, 6402 (2020). https:\/\/doi.org\/10.1038\/s41467-020-20228-7","journal-title":"Nat. Commun."},{"key":"18_CR64","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41392-021-00797-9","volume":"6","author":"H Li","year":"2021","unstructured":"Li, H., et al.: Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein. Signal Transduct. Target. Ther. 6, 389 (2021). https:\/\/doi.org\/10.1038\/s41392-021-00797-9","journal-title":"Signal Transduct. Target. Ther."},{"key":"18_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.788235","volume":"12","author":"KL O'Donnell","year":"2021","unstructured":"O'Donnell, K.L., et al.: Optimization of single-dose VSV-based COVID-19 vaccination in hamsters. Front. Immunol. 12, 788235 (2021). https:\/\/doi.org\/10.3389\/fimmu.2021.788235","journal-title":"Front. Immunol."},{"key":"18_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.793437","volume":"8","author":"LS Ding","year":"2021","unstructured":"Ding, L.S., et al.: Growth, antigenicity, and immunogenicity of SARS-CoV-2 spike variants revealed by a live rVSV-SARS-CoV-2 virus. Front. Med (Lausanne). 8, 793437 (2021). https:\/\/doi.org\/10.3389\/fmed.2021.793437","journal-title":"Front. Med (Lausanne)."},{"key":"18_CR67","doi-asserted-by":"publisher","unstructured":"Yahalom-Ronen, Y., et al.: Neutralization of SARS-CoV-2 variants by rVSV-DeltaG-spike-elicited human sera. Vaccines (Basel). 10 (2022). https:\/\/doi.org\/10.3390\/vaccines10020291","DOI":"10.3390\/vaccines10020291"}],"container-title":["Advances in Experimental Medicine and Biology","Pseudotyped Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-99-0113-5_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:25:44Z","timestamp":1678879544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-99-0113-5_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9789819901128","9789819901135"],"references-count":67,"URL":"https:\/\/doi.org\/10.1007\/978-981-99-0113-5_18","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"16 March 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}